Showing results (171-180 of 400) with videos related to
Sort By:
Pageof 40
Thrombosis Research|July 1, 1990
Heparin-induced platelet aggregation. II. Dose/response relationships for two low molecular weight heparin fractions (CY 216 and CY 222)L D Brace, J FareedThrombosis Research|June 15, 1997
Vasomodulatory action of clopidogrel and ticlopidineL H Yang, J FareedSeminars in Thrombosis and Hemostasis|April 1, 1985
An objective assessment of the interaction of heparin and its fractions with human plateletsL D Brace, J FareedThrombosis Research|June 15, 1986
Heparin-induced platelet aggregation: dose/response relationships for a low molecular weight heparin derivative (PK 10169) and its subfractionsL D Brace, J FareedMinerva Chirurgica|May 31, 1989
[A multicenter study of defibrotide in the prevention of deep venous thrombosis. Final results]C Gerosa, A B Calvani, U Cornelli, et al.Panminerva Medica|November 24, 2011
Pycnogenol® supplementation improves cognitive function, attention and mental performance in studentsR Luzzi, G Belcaro, C Zulli, et al.Angiology|May 25, 2004
Variations in plasma free radicals with topical aescin + essential phospholipids gel in venous hypertension: new clinical dataA Ricci, I Ruffini, M R Cesarone, et al.Panminerva Medica|July 27, 2010
Antilip®: treatment of subjects with high total cholesterol tolerability and efficacy in a short-term registry studyM R Cesarone, A Ledda, G Belcaro, et al.The Annals of Thoracic Surgery|April 1, 1996
Aprotinin modulation of platelet activation in patients undergoing cardiopulmonary bypass operationsC Primack, J M Walenga, M J Koza, et al.Seminars in Thrombosis and Hemostasis|January 1, 1996
Plasma levels of the molecular markers of coagulation and fibrinolysis in patients with peripheral arterial diseaseA Strano, D Hoppensteadt, J M Walenga, et al.Pageof 40